Notification of major interest in shares

RNS Number : 1149M

Alliance Pharma PLC

10 August 2011

 



For Immediate Release

10  August 2011

Alliance Pharma plc

TR-1: Notification of major interest in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Alliance Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached				n/a
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments				n/a
An event changing the breakdown of voting rights				n/a
Other (please specify):	On market transfer between direct and indirect funds			n/a
3. Full name of person(s) subject to the notification obligation:		NIGEL WRAY
4. Full name of shareholder(s)  (if different from 3.):		PERSHING NOMINEES LIMITED      SMITH & WILLIAMSON NOMINEES LIMITED ROY NOMINEES LIMITED
5. Date of the transaction and date on which the threshold is crossed or reached:		9th August 2011
6. Date on which issuer notified:		10 August 2011
7. Threshold(s) that is/are crossed or reached:		14%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary shares GB0031030819

31,119,995

31,119,995

33,619,995

9,455,407

24,164,588

3.95%

10.09%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

33,619,995

14.04%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Nigel William Wray has a beneficial interest in shares in Alliance Pharma Plc held by the following nominees Pershing Nominees Limited 9,405,407 Smith & Williamson Nominees Limited 50,000  The family of Nigel Wray maintains a beneficial interest in the shares held by Roy Nominees Limited   - 24,164,588
Proxy Voting:
10. Name of the proxy holder:	n/a
11. Number of voting rights proxy holder will cease to hold:	n/a
12. Date on which proxy holder will cease to hold voting rights:	n/a
13. Additional information:		Figures are based on a total number of voting rights of 239,394,534
14. Contact name:		Nigel Wray
15. Contact telephone number:		020 7647 7647

 

END

 

 

HOLEAAPEFFNFEFF